Written on Mar, 06, 2005
by DrB
By Ransdell Pierson NEW YORK (Reuters) – Pfizer Inc.’s experimental drug to raise “good” HDL cholesterol was effective and well tolerated in two small mid-stage trials, but appeared to cause a small increase in blood pressure among some patients, according to industry analysts.…
Written on Mar, 06, 2005
by DrB
Experimental Cholesterol Drug Raises Blood Pressure: A new drug being tested by Pfizer that raises the amount of HDL cholesterol also triggers an increase in blood pressure in some patients, offsetting any benefit according to experts. A complete report of the research will…
Written on Mar, 04, 2005
by DrB
Public Citizen Press Releases Providing the latest information about Public Citizen activities ——————————————- Statement of Sidney M. Wolfe, MD, Director, Public Citizen’s Health Research Group Today’s announcement by the U.S. Food and Drug Administration (FDA) concerning revised labeling of the cholesterol-lowering drug Crestor…
Written on Mar, 01, 2005
by DrB
How much protection do vaccines provide seniors? According to a study I posted a couple of weeks ago, the benefit was virtually nonexistent. A new study of seniors has discovered another not-so-shocking fact that can also harm their health: Almost 29 percent of…
Written on Mar, 01, 2005
by DrB
CBS 2 Chicago WBBM-TV | cbs2chicago.com Sales Of New MS Drug Suspended FDA Approved Drug In November The makers of Tysabri, a new drug used to treat multiple sclerosis, announced Monday they are voluntarily suspending sales of the drug after one patient died…
Written on Feb, 26, 2005
by DrB
Study: Drug for Agitation Makes Alzheimer’s Patients Worse February 18, 2005 (British Medical Journal) — Quetiapine, a drug commonly used in nursing homes to treat agitation and related symptoms in people with Alzheimer’s disease actually worsens patients’ illness, speeding up their rate of…